Gebelik ve Tiroid Hastalıkları
Özet
Gebelik sürecinde tiroid hormonları; embriyonel ve fetal gelişim ile anne sağlığı üzerinde derin etkilere sahiptir. Bu dönemde, insan koryonik gonadotropini (hCG) artışı ve östrojen hormonuna bağlı olarak tiroksin bağlayıcı globulin (TBG) sentezinin yükselmesi gibi önemli fizyolojik adaptasyonlar meydana gelir. İlk trimesterde hCG zirvesiyle birlikte serum TSH düzeylerinde geçici bir düşüş gözlenirken, total T3 ve T4 seviyeleri artış gösterir. Ayrıca artan glomerular filtrasyon hızı iyodürün renal klirensini artırır ve bu durum günlük iyot ihtiyacını yükseltir. Fetal tiroid bezi gebeliğin 18-20. haftalarına kadar olgunlaşmadığı için, erken dönem gelişim tamamen anneden plasenta yoluyla geçen T4 hormonuna bağımlıdır. Annede gelişen aşikar hipotiroidizm ve hipertiroidizm (en sık Graves hastalığı); düşük, preeklampsi, erken doğum ve çocukta bilişsel gerilik gibi olumsuz obstetrik sonuçlara yol açabileceğinden minimum doz antitiroid ilaçlar veya levotiroksin ile tedavi edilmelidir. Subklinik hipotiroidizm ve izole maternal hipotiroksinemi tedavisi ise halen tartışmalıdır. Tiroid nodülleri ve kanseri yönetiminde tanı için ince iğne aspirasyon biyopsisi (İİAB) kullanılırken, cerrahi genellikle postpartum döneme ertelenir. Doğum sonrası ilk yılda görülen doğum sonrası tiroidit (DST) ise genellikle kendini sınırlayan, bifazik ve otoimmün bir tablodur.
During pregnancy, thyroid hormones exert profound effects on embryonal, fetal development, and maternal health. Significant physiological adaptations occur during this period, including an increase in human chorionic gonadotropin (hCG) and elevated hepatic synthesis of thyroxine-binding globulin (TBG) driven by rising estrogen levels. Consequently, a transient decrease in serum TSH levels is observed during the first trimester corresponding to peak hCG levels, while total T3 and T4 levels increase. Furthermore, an increased glomerular filtration rate elevates the renal clearance of iodide, raising daily iodine requirements. Since the fetal thyroid gland does not mature until the 18th to 20th weeks of gestation, early development depends entirely on maternal T4 transferred across the placenta. Overt maternal hypothyroidism and hyperthyroidism (most commonly Graves' disease) can lead to adverse obstetric outcomes such as miscarriage, preeclampsia, preterm birth, and impaired fetal neurodevelopment; therefore, they must be managed with minimal doses of antithyroid drugs or levothyroxine. Conversely, the management of subclinical hypothyroidism and isolated maternal hypothyroxinemia remains controversial. For thyroid nodules and differentiated thyroid cancer, fine-needle aspiration biopsy (FNAB) is utilized for diagnosis, while surgical intervention is typically postponed to the postpartum period. Lastly, postpartum thyroiditis (PPT), presenting within the first year after delivery, is generally a self-limiting, biphasic, and autoimmune condition.
Referanslar
Hershman JM. Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract Res Clin Endocrinol Metab. 2004;18(2):249-65. Epub 2004/05/26.
Ballabio M, Poshychinda M, Ekins RP. Pregnancy-induced changes in thyroid function: role of human chorionic gonadotropin as putative regulator of maternal thyroid. J Clin Endocrinol Metab. 1991;73(4):824-31. Epub 1991/10/01.
Burrow GN, Fisher DA, Larsen PR. Maternal and fetal thyroid function. N Engl J Med. 1994;331(16):1072-8. Epub 1994/10/20.
Glinoer D, De Nayer P, Robyn C, Lejeune B, Kinthaert J, Meuris S. Serum levels of intact human chorionic gonadotropin (HCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy. J Endocrinol Invest. 1993;16(11):881-8. Epub 1993/12/01.
Grun JP, Meuris S, De Nayer P, Glinoer D. The thyrotrophic role of human chorionic gonadotrophin (hCG) in the early stages of twin (versus single) pregnancies. Clin Endocrinol (Oxf). 1997;46(6):719-25. Epub 1997/06/01.
Hershman JM, Lee HY, Sugawara M, Mirell CJ, Pang XP, Yanagisawa M, et al. Human chorionic gonadotropin stimulates iodide uptake, adenylate cyclase, and deoxyribonucleic acid synthesis in cultured rat thyroid cells. J Clin Endocrinol Metab. 1988;67(1):74-9. Epub 1988/07/01.
Bartalena L. Recent achievements in studies on thyroid hormone-binding proteins. Endocr Rev. 1990;11(1):47-64. Epub 1990/02/01.
Alemu A, Terefe B, Abebe M, Biadgo B. Thyroid hormone dysfunction during pregnancy: A review. Int J Reprod Biomed. 2016;14(11):677-86. Epub 2016/12/17.
J R. Thyroid hormone transport proteins and the physiology of hormone binding. In: In: Braverman LE UReTT, ed 7, editor.: JB Lippincott; 1996. p. 96 -111.
Jacobsen BB, Peitersen B, Andersen HJ, Hummer L. Serum concentrations of thyroxine-binding globulin, prealbumin and albumin in healthy fullterm, small-for-gestational age and preterm newborn infants. Acta Paediatr Scand. 1979;68(1):49-55. Epub 1979/01/01.
Ain KB, Mori Y, Refetoff S. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metab. 1987;65(4):689-96. Epub 1987/10/01.
Robert Resnik CJL, Thomas Moore, Michael F Greene, Joshua Copel, Robert M Silver. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice 8th Edition ed: Saunders Elsevier Philadelphia; 2019.
Weeke J, Dybkjaer L, Granlie K, Eskjaer Jensen S, Kjaerulff E, Laurberg P, et al. A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. Acta Endocrinol (Copenh). 1982;101(4):531-7. Epub 1982/12/01.
Huang SA. Physiology and pathophysiology of type 3 deiodinase in humans. Thyroid. 2005;15(8):875-81. Epub 2005/09/01.
Moleti M, Trimarchi F, Vermiglio F. Thyroid physiology in pregnancy. Endocr Pract. 2014;20(6):589-96. Epub 2014/01/23.
Davison JM. The kidney in pregnancy: a review. J R Soc Med. 1983;76(6):485-501. Epub 1983/06/01.
Cheung CK, Lao T, Swaminathan R. Urinary excretion of some proteins and enzymes during normal pregnancy. Clin Chem. 1989;35(9):1978-80. Epub 1989/09/01.
Lazarus J. Thyroid Regulation and Dysfunction in the Pregnant Patient. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, et al., editors. Endotext. South Dartmouth (MA)2000.
Stewart WB RL. Embryology and surgical anatomy of the thyroid and parathyroid glands. Oertli D UR, editor2012.
Glinoer D, Delange F. The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid. 2000;10(10):871-87. Epub 2000/11/18.
Ray JG. Preconception-initiated, low-dose aspirin did not increase live birth after 1 or 2 pregnancy losses. Ann Intern Med. 2014;161(6):JC13. Epub 2014/09/16.
LaFranchi S. Thyroid function in the preterm infant. Thyroid. 1999;9(1):71-8. Epub 1999/02/26.
Chapman AK, Farmer ZJ, Mastrandrea LD, Matlock KA. Neonatal Thyroid Function and Disorders. Clin Obstet Gynecol. 2019;62(2):373-87. Epub 2019/04/27.
Fisher DA. Hypothyroxinemia in premature infants: is thyroxine treatment necessary? Thyroid. 1999;9(7):715-20. Epub 1999/08/14.
Huppertz B. The anatomy of the normal placenta. J Clin Pathol. 2008;61(12):1296-302. Epub 2008/08/30.
Myllynen P, Immonen E, Kummu M, Vahakangas K. Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues. Expert Opin Drug Metab Toxicol. 2009;5(12):1483-99. Epub 2009/09/30.
Vulsma T, Gons MH, de Vijlder JJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med. 1989;321(1):13-6. Epub 1989/07/06.
Calvo RM, Jauniaux E, Gulbis B, Asuncion M, Gervy C, Contempre B, et al. Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab. 2002;87(4):1768-77. Epub 2002/04/05.
Costa A, Arisio R, Benedetto C, Bertino E, Fabris C, Giraudi G, et al. Thyroid hormones in tissues from human embryos and fetuses. J Endocrinol Invest. 1991;14(7):559-68. Epub 1991/07/01.
Chan S, Kachilele S, Hobbs E, Bulmer JN, Boelaert K, McCabe CJ, et al. Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. J Clin Endocrinol Metab. 2003;88(9):4488-95. Epub 2003/09/13.
Chan SY, Franklyn JA, Pemberton HN, Bulmer JN, Visser TJ, McCabe CJ, et al. Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J Endocrinol. 2006;189(3):465-71. Epub 2006/05/30.
Sato K, Sugawara J, Sato T, Mizutamari H, Suzuki T, Ito A, et al. Expression of organic anion transporting polypeptide E (OATP-E) in human placenta. Placenta. 2003;24(2-3):144-8. Epub 2003/02/05.
Loubiere LS, Vasilopoulou E, Bulmer JN, Taylor PM, Stieger B, Verrey F, et al. Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction. Placenta. 2010;31(4):295-304. Epub 2010/02/20.
Koopdonk-Kool JM, de Vijlder JJ, Veenboer GJ, Ris-Stalpers C, Kok JH, Vulsma T, et al. Type II and type III deiodinase activity in human placenta as a function of gestational age. J Clin Endocrinol Metab. 1996;81(6):2154-8. Epub 1996/06/01.
Stulp MR, de Vijlder JJ, Ris-Stalpers C. Placental iodothyronine deiodinase III and II ratios, mRNA expression compared to enzyme activity. Mol Cell Endocrinol. 1998;142(1-2):67-73. Epub 1998/10/23.
Kilby MD, Barber K, Hobbs E, Franklyn JA. Thyroid hormone action in the placenta. Placenta. 2005;26(2-3):105-13. Epub 2005/02/15.
Burns R, O'Herlihy C, Smyth PP. The placenta as a compensatory iodine storage organ. Thyroid. 2011;21(5):541-6. Epub 2011/03/23.
Carrasco N. Iodide transport in the thyroid gland. Biochim Biophys Acta. 1993;1154(1):65-82. Epub 1993/06/08.
Bizhanova A, Kopp P. Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinology. 2009;150(3):1084-90. Epub 2009/02/07.
Bidart JM, Lacroix L, Evain-Brion D, Caillou B, Lazar V, Frydman R, et al. Expression of Na+/I- symporter and Pendred syndrome genes in trophoblast cells. J Clin Endocrinol Metab. 2000;85(11):4367-72. Epub 2000/11/30.
Zimmermann MB. The effects of iodine deficiency in pregnancy and infancy. Paediatr Perinat Epidemiol. 2012;26 Suppl 1:108-17. Epub 2012/07/07.
Berghout A, Wiersinga W. Thyroid size and thyroid function during pregnancy: an analysis. Eur J Endocrinol. 1998;138(5):536-42. Epub 1998/06/13.
Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 1997;18(3):404-33. Epub 1997/06/01.
Glinoer D, De Nayer P, Delange F, Lemone M, Toppet V, Spehl M, et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. J Clin Endocrinol Metab. 1995;80(1):258-69. Epub 1995/01/01.
Eastman CJ, Zimmermann MB. The Iodine Deficiency Disorders. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, et al., editors. Endotext. South Dartmouth (MA)2000.
Cao XY, Jiang XM, Dou ZH, Rakeman MA, Zhang ML, O'Donnell K, et al. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. N Engl J Med. 1994;331(26):1739-44. Epub 1994/12/29.
DeLong GR, Leslie PW, Wang SH, Jiang XM, Zhang ML, Rakeman M, et al. Effect on infant mortality of iodination of irrigation water in a severely iodine-deficient area of China. Lancet. 1997;350(9080):771-3. Epub 1997/09/23.
Moreno-Reyes R, Glinoer D, Van Oyen H, Vandevijvere S. High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: a population-based study. J Clin Endocrinol Metab. 2013;98(9):3694-701. Epub 2013/07/13.
Olivares JL, Olivi GI, Verdasco C, Ortiz VA, Mayer MA, Cresto JC. Low iodine intake during pregnancy: relationship to placental development and head circumference in newborn. Endocrinol Nutr. 2012;59(5):326-30. Epub 2012/03/03.
Pearce EN. What do we know about iodine supplementation in pregnancy? J Clin Endocrinol Metab. 2009;94(9):3188-90. Epub 2009/09/08.
Andersson M, de Benoist B, Delange F, Zupan J. Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2-years-old: conclusions and recommendations of the Technical Consultation. Public Health Nutr. 2007;10(12A):1606-11. Epub 2008/03/11.
Glinoer D, de Nayer P, Bourdoux P, Lemone M, Robyn C, van Steirteghem A, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab. 1990;71(2):276-87. Epub 1990/08/01.
Soldin OP, Tractenberg RE, Hollowell JG, Jonklaas J, Janicic N, Soldin SJ. Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency. Thyroid. 2004;14(12):1084-90. Epub 2005/01/15.
Li C, Shan Z, Mao J, Wang W, Xie X, Zhou W, et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women? J Clin Endocrinol Metab. 2014;99(1):73-9. Epub 2013/11/28.
Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315-89. Epub 2017/01/07.
van Dijk MM, Smits IH, Fliers E, Bisschop PH. Maternal Thyrotropin Receptor Antibody Concentration and the Risk of Fetal and Neonatal Thyrotoxicosis: A Systematic Review. Thyroid. 2018;28(2):257-64. Epub 2018/01/13.
Lee RH, Spencer CA, Mestman JH, Miller EA, Petrovic I, Braverman LE, et al. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol. 2009;200(3):260 e1-6. Epub 2008/12/31.
Poppe K, Velkeniers B, Glinoer D. The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab. 2008;4(7):394-405. Epub 2008/05/29.
Bussen S, Steck T. Thyroid autoantibodies in euthyroid non-pregnant women with recurrent spontaneous abortions. Hum Reprod. 1995;10(11):2938-40. Epub 1995/11/01.
Yim CH. Update on the Management of Thyroid Disease during Pregnancy. Endocrinol Metab (Seoul). 2016;31(3):386-91. Epub 2016/08/23.
Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31(5):702-55. Epub 2010/06/25.
Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos RJ, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen. 2000;7(3):127-30. Epub 2000/12/29.
Kahaly GJ, Diana T, Olivo PD. Tsh Receptor Antibodies: Relevance & Utility. Endocr Pract. 2020;26(1):97-106. Epub 2020/02/06.
Mannisto T, Mendola P, Grewal J, Xie Y, Chen Z, Laughon SK. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab. 2013;98(7):2725-33. Epub 2013/06/08.
Howdeshell KL. A model of the development of the brain as a construct of the thyroid system. Environ Health Perspect. 2002;110 Suppl 3:337-48. Epub 2002/06/13.
Bernal J, Guadano-Ferraz A, Morte B. Perspectives in the study of thyroid hormone action on brain development and function. Thyroid. 2003;13(11):1005-12. Epub 2003/12/04.
Moog NK, Entringer S, Heim C, Wadhwa PD, Kathmann N, Buss C. Influence of maternal thyroid hormones during gestation on fetal brain development. Neuroscience. 2017;342:68-100. Epub 2015/10/06.
Andersen SL, Andersen S, Liew Z, Vestergaard P, Olsen J. Maternal Thyroid Function in Early Pregnancy and Neuropsychological Performance of the Child at 5 Years of Age. J Clin Endocrinol Metab. 2018;103(2):660-70. Epub 2017/12/09.
Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341(8):549-55. Epub 1999/08/19.
Thyroid Disease in Pregnancy: ACOG Practice Bulletin, Number 223. Obstet Gynecol. 2020;135(6):e261-e74. Epub 2020/05/23.
Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med. 2001;344(23):1743-9. Epub 2001/06/09.
Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004;351(3):241-9. Epub 2004/07/16.
Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol. 2008;112(1):85-92. Epub 2008/07/02.
Sheehan PM, Nankervis A, Araujo Junior E, Da Silva Costa F. Maternal Thyroid Disease and Preterm Birth: Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2015;100(11):4325-31. Epub 2015/09/19.
Liu H, Shan Z, Li C, Mao J, Xie X, Wang W, et al. Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study. Thyroid. 2014;24(11):1642-9. Epub 2014/08/05.
Maraka S, Ospina NM, O'Keeffe DT, Espinosa De Ycaza AE, Gionfriddo MR, Erwin PJ, et al. Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis. Thyroid. 2016;26(4):580-90. Epub 2016/02/04.
Korevaar TIM, Derakhshan A, Taylor PN, Meima M, Chen L, Bliddal S, et al. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis. JAMA. 2019;322(7):632-41. Epub 2019/08/21.
Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Alavi Majd H, Azizi F. Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease. Eur J Endocrinol. 2017;176(2):253-65. Epub 2016/11/24.
Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Minooee S, Rahmati M, et al. Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism, Negative for Thyroid Peroxidase Antibodies. J Clin Endocrinol Metab. 2018;103(3):926-35. Epub 2017/11/11.
Nazarpour S, Ramezani Tehrani F, Amiri M, Bidhendi Yarandi R, Azizi F. Levothyroxine treatment and pregnancy outcomes in women with subclinical hypothyroidism: a systematic review and meta-analysis. Arch Gynecol Obstet. 2019;300(4):805-19. Epub 2019/08/11.
Hales C, Taylor PN, Channon S, Paradice R, McEwan K, Zhang L, et al. Controlled Antenatal Thyroid Screening II: Effect of Treating Maternal Suboptimal Thyroid Function on Child Cognition. J Clin Endocrinol Metab. 2018;103(4):1583-91. Epub 2018/01/19.
Tozzoli R, Bagnasco M, Giavarina D, Bizzaro N. TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis. Autoimmun Rev. 2012;12(2):107-13. Epub 2012/07/11.
Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105(2):239-45. Epub 2005/02/03.
Sheffield JS, Cunningham FG. Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol. 2004;190(1):211-7. Epub 2004/01/30.
Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994;84(6):946-9. Epub 1994/12/01.
Wang MT, Lee WJ, Huang TY, Chu CL, Hsieh CH. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study. Br J Clin Pharmacol. 2014;78(3):619-29. Epub 2014/10/04.
Suzuki N, Noh JY, Hiruma M, Kawaguchi A, Morisaki M, Ohye H, et al. Analysis of Antithyroid Drug-Induced Severe Liver Injury in 18,558 Newly Diagnosed Patients with Graves' Disease in Japan. Thyroid. 2019;29(10):1390-8. Epub 2019/10/02.
Arab DM, Malatjalian DA, Rittmaster RS. Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole. J Clin Endocrinol Metab. 1995;80(4):1083-5. Epub 1995/04/01.
Woeber KA. Methimazole-induced hepatotoxicity. Endocr Pract. 2002;8(3):222-4. Epub 2002/12/07.
Rivkees SA, Szarfman A. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab. 2010;95(7):3260-7. Epub 2010/04/30.
Mortimer RH, Cannell GR, Addison RS, Johnson LP, Roberts MS, Bernus I. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab. 1997;82(9):3099-102. Epub 1997/09/01.
Rosenfeld H, Ornoy A, Shechtman S, Diav-Citrin O. Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study. Br J Clin Pharmacol. 2009;68(4):609-17. Epub 2009/10/22.
Andersen SL, Olsen J, Wu CS, Laurberg P. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metab. 2013;98(11):4373-81. Epub 2013/10/24.
Andersen SL, Olsen J, Wu CS, Laurberg P. Severity of birth defects after propylthiouracil exposure in early pregnancy. Thyroid. 2014;24(10):1533-40. Epub 2014/06/26.
Andersen SL, Knosgaard L, Olsen J, Vestergaard P, Andersen S. Maternal Thyroid Function, Use of Antithyroid Drugs in Early Pregnancy, and Birth Defects. J Clin Endocrinol Metab. 2019;104(12):6040-8. Epub 2019/08/14.
Andersen SL, Lonn S, Vestergaard P, Torring O. Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study. Eur J Endocrinol. 2017;177(4):369-78. Epub 2017/08/07.
Lydakis C, Lip GY, Beevers M, Beevers DG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens. 1999;12(6):541-7. Epub 1999/06/17.
Sisson JC, Freitas J, McDougall IR, Dauer LT, Hurley JR, Brierley JD, et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association. Thyroid. 2011;21(4):335-46. Epub 2011/03/23.
Momotani N, Noh JY, Ishikawa N, Ito K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab. 1997;82(11):3633-6. Epub 1997/11/14.
Pearce EN. Management of Thyrotoxicosis: Preconception, Pregnancy, and the Postpartum Period. Endocr Pract. 2019;25(1):62-8. Epub 2018/10/06.
Abeillon-du Payrat J, Chikh K, Bossard N, Bretones P, Gaucherand P, Claris O, et al. Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism. Eur J Endocrinol. 2014;171(4):451-60. Epub 2014/09/13.
Goodwin TM, Montoro M, Mestman JH. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol. 1992;167(3):648-52. Epub 1992/09/01.
Yoshihara A, Noh JY, Mukasa K, Suzuki M, Ohye H, Matsumoto M, et al. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT? Endocr J. 2015;62(6):557-60. Epub 2015/03/31.
Kinomoto-Kondo S, Umehara N, Sato S, Ogawa K, Fujiwara T, Arata N, et al. The effects of gestational transient thyrotoxicosis on the perinatal outcomes: a case-control study. Arch Gynecol Obstet. 2017;295(1):87-93. Epub 2016/10/22.
Kung AW, Chau MT, Lao TT, Tam SC, Low LC. The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab. 2002;87(3):1010-4. Epub 2002/03/13.
Glinoer D, Soto MF, Bourdoux P, Lejeune B, Delange F, Lemone M, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab. 1991;73(2):421-7. Epub 1991/08/01.
Karger S, Schotz S, Stumvoll M, Berger F, Fuhrer D. Impact of pregnancy on prevalence of goitre and nodular thyroid disease in women living in a region of borderline sufficient iodine supply. Horm Metab Res. 2010;42(2):137-42. Epub 2009/11/03.
Martin JA, Hamilton BE, Osterman MJ, Driscoll AK, Mathews TJ. Births: Final Data for 2015. Natl Vital Stat Rep. 2017;66(1):1. Epub 2017/01/31.
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133. Epub 2015/10/16.
Messuti I, Corvisieri S, Bardesono F, Rapa I, Giorcelli J, Pellerito R, et al. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features. Eur J Endocrinol. 2014;170(5):659-66. Epub 2014/02/11.
Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2009;19(11):1159-65. Epub 2009/11/06.
Herzon FS, Morris DM, Segal MN, Rauch G, Parnell T. Coexistent thyroid cancer and pregnancy. Arch Otolaryngol Head Neck Surg. 1994;120(11):1191-3. Epub 1994/11/01.
Moosa M, Mazzaferri EL. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab. 1997;82(9):2862-6. Epub 1997/09/01.
Vannucchi G, Perrino M, Rossi S, Colombo C, Vicentini L, Dazzi D, et al. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol. 2010;162(1):145-51. Epub 2009/10/16.
Rosario PW, Barroso AL, Purisch S. The effect of subsequent pregnancy on patients with thyroid carcinoma apparently free of the disease. Thyroid. 2007;17(11):1175-6. Epub 2007/12/01.
Driouich Y, Haraj NE, El Aziz S, Chadli A. Impact of pregnancy on papillary thyroid carcinoma prognosis. Pan Afr Med J. 2021;38:261. Epub 2021/06/15.
Stagnaro-Green A. Approach to the patient with postpartum thyroiditis. J Clin Endocrinol Metab. 2012;97(2):334-42. Epub 2012/02/09.
Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev. 2001;22(5):605-30. Epub 2001/10/06.
Kuijpens JL, De Hann-Meulman M, Vader HL, Pop VJ, Wiersinga WM, Drexhage HA. Cell-mediated immunity and postpartum thyroid dysfunction: a possibility for the prediction of disease? J Clin Endocrinol Metab. 1998;83(6):1959-66. Epub 1998/06/17.
Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Wallenstein S, Davies TF. A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction. J Clin Endocrinol Metab. 1992;74(3):645-53. Epub 1992/03/01.
Nguyen CT, Mestman JH. Postpartum Thyroiditis. Clin Obstet Gynecol. 2019;62(2):359-64. Epub 2019/03/08.
Gerstein HC. Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitus. Ann Intern Med. 1993;118(6):419-23. Epub 1993/03/15.
Di Bari F, Granese R, Le Donne M, Vita R, Benvenga S. Autoimmune Abnormalities of Postpartum Thyroid Diseases. Front Endocrinol (Lausanne). 2017;8:166. Epub 2017/07/29.
Bergink V, Pop VJM, Nielsen PR, Agerbo E, Munk-Olsen T, Liu X. Comorbidity of autoimmune thyroid disorders and psychiatric disorders during the postpartum period: a Danish nationwide register-based cohort study. Psychol Med. 2018;48(8):1291-8. Epub 2017/09/21.
Nikolai TF, Turney SL, Roberts RC. Postpartum lymphocytic thyroiditis. Prevalence, clinical course, and long-term follow-up. Arch Intern Med. 1987;147(2):221-4. Epub 1987/02/01.
Lazarus JH, Hall R, Othman S, Parkes AB, Richards CJ, McCulloch B, et al. The clinical spectrum of postpartum thyroid disease. QJM. 1996;89(6):429-35. Epub 1996/06/01.
Gerstein HC. How common is postpartum thyroiditis? A methodologic overview of the literature. Arch Intern Med. 1990;150(7):1397-400. Epub 1990/07/01.
